Miguel
Cervero Jiménez
Publicaciones (76) Publicaciones de Miguel Cervero Jiménez
2024
-
Corrigendum to: “Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D” [Biomed. Pharmacother. 150 (2022) 1−11] (Biomedicine & Pharmacotherapy (2022) 150, (S0753332222003547), (10.1016/j.biopha.2022.112965))
Biomedicine and Pharmacotherapy
-
Dasatinib interferes with HIV-1 proviral integration and the inflammatory potential of monocyte-derived macrophages from people with HIV
Biochemical Pharmacology, Vol. 229
-
Different polarization and functionality of CD4+ T helper subsets in people with post-COVID condition
Frontiers in Immunology, Vol. 15
-
Effectiveness and Safety of Direct-acting Antivirals for Treatment of Adolescents With HCV/HIV Coinfection: Real-world Data From Europe
Pediatric Infectious Disease Journal, Vol. 43, Núm. 5, pp. E155-E159
-
Incidence of Diabetes Mellitus and Associated Factors in the Era of Antiretroviral Drugs With a Low Metabolic Toxicity Profile
Open Forum Infectious Diseases, Vol. 11, Núm. 4
-
Pre-existing cell populations with cytotoxic activity against SARS-CoV-2 in people with HIV and normal CD4/CD8 ratio previously unexposed to the virus
Frontiers in Immunology, Vol. 15
-
Prospective study for the early detection of lung carcinoma in patients with HIV infection (GESIDA study 8815)
Enfermedades Infecciosas y Microbiologia Clinica
-
Sustained antiviral response against in vitro HIV-1 infection in peripheral blood mononuclear cells from people with chronic myeloid leukemia treated with ponatinib
Frontiers in Pharmacology, Vol. 15
2023
-
HIV medical care interruption among people living with HIV in Spain, 2004-2020
AIDS, Vol. 37, Núm. 8, pp. 1277-1284
-
Patterns of Sexualized Drug Use among Gay, Bisexual, and Other Men Who Have Sex with Men Living with HIV: Insights from a Comprehensive Study—The U-SEX-2 GESIDA 9416 Study
Journal of Clinical Medicine, Vol. 12, Núm. 23
2022
-
Amikacin pharmacokinetics in elderly patients with severe infections
European Journal of Pharmaceutical Sciences, Vol. 175
-
Association of Latin-American Ethnicity with an Increase in Weight in an HIV-Infected Outpatient Population
Infectious Diseases and Therapeutics, Vol. 3, Núm. 1
-
Beneficial Effect of Short-Term Supplementation of High Dose of Vitamin D3 in Hospitalized Patients With COVID-19: A Multicenter, Single-Blinded, Prospective Randomized Pilot Clinical Trial
Frontiers in Pharmacology, Vol. 13
-
Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
Biomedicine & Pharmacotherapy, Vol. 150, pp. 112965
-
Changes in the immune response against SARS-CoV-2 in individuals with severe COVID-19 treated with high dose of vitamin D
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, Vol. 150, pp. 112965
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Dolutegravir plus rilpivirine: benefits beyond viral suppression: DORIPEX retrospective study
Medicine (United States), Vol. 101, Núm. 24, pp. E29252
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Reply: «Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure»
Medicina Clinica
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876